Rocket Pharmaceuticals Warrant
RCKTW
14 hedge funds and large institutions have $904K invested in Rocket Pharmaceuticals Warrant in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0.2% less ownership
Funds ownership: 3.74% → 3.54% (-0.2%)
10% less capital invested
Capital invested by funds: $1M → $904K (-$98.7K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$8 |
| 2 |
CS
Clear Street
New York
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.12K |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$4.68K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1 |
RCKTW Hedge Fund Activity: Q3 2024 in Review
14 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q3 2024, worth a combined $904K — down 9.8% from $1M a quarter earlier.
Fund positioning in RCKTW was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $8. The largest seller was Susquehanna International Group, cutting an estimated $6.12K.
- 14 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $904K of Rocket Pharmaceuticals Warrant stock for Q3 2024, down 9.8% quarter-over-quarter.
- 2 funds opened new Rocket Pharmaceuticals Warrant positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest Rocket Pharmaceuticals Warrant buyer in Q3 2024 was Bank of America, an estimated $8 added.
- The largest Rocket Pharmaceuticals Warrant seller in Q3 2024 was Susquehanna International Group, an estimated $6.12K sold.
Based on aggregated 13F filings for Q3 2024.